NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") ICLR of...
Linical Accelovance Competitors or Alternatives
Linical Accelovance's top competitors include Medpace, Chiltern and Toxikon.
Linical Accelovance VS Medpace
Medpace is a top competitor of Linical Accelovance. Medpace was founded in Cincinnati, Ohio} in 1992. Medpace competes in the Health Care Services industry. Compared to Linical Accelovance, Medpace generates $2B more revenue.
Linical Accelovance VS Chiltern
Chiltern is Linical Accelovance's #2 competitor. Chiltern is headquartered in Berkshire, England, and was founded in 1982. Chiltern competes in the Biotechnology field. Chiltern generates 1,000% the revenue of Linical Accelovance.
Linical Accelovance VS Toxikon
Toxikon has been one of Linical Accelovance's top competitors. Toxikon is a Private company that was founded in 1977 in Bedford, Massachusetts. Like Linical Accelovance, Toxikon also competes in the Pharmaceuticals & Biotechnology industry. Compared to Linical Accelovance, Toxikon has 50 more employees.
Looking for similar companies to Linical Accelovance?
Similar Companies
Companies in Stuart with employees in 100-250 range
See 88 companies
Biotechnology companies in Miami Metropolitan AreaSee 230 companies
Companies in Stuart with revenue in $25-100M rangeSee 120 companies
Pharmaceuticals & Biotechnology companies in Miami Metropolitan AreaSee 421 companies
Biotechnology companies in FloridaSee 553 companies
Biotechnology companies with revenue in $25-100M rangeSee 854 companies
Pharmaceuticals & Biotechnology companies in FloridaSee 979 companies
Biotechnology companies with employees in 100-250 rangeSee 1,100 companies
Pharmaceuticals & Biotechnology companies with revenue in $25-100M rangeSee 1,446 companies
Trending News for Linical Accelovance and Linical Accelovance's Competitors
WASHINGTON (dpa-AFX) - Labcorp (LH), Tuesday announced it will offer nationwide a U.S. Food and Drug Administration (FDA) approved human papillomavirus...
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro....
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of ICON plc (...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ICON To Contact Him Directly To Disc...
ICLR Investors are Reminded of Final Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm PR Newswire LOS ...
Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's......
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / April 2, 2025 / Bleichmar Fonti & Auld LLP ("BFA") announces that it has filed a class action law...
Eli Lilly has sued two large compounding pharmacies, alleging they deceive patients and put them at risk with compounded versions of the obesity drug t...
Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound.Re...
Frequently Asked Questions about Linical Accelovance
Who are Linical Accelovance's top competitors?
Linical Accelovance's top 3 competitors are Medpace, Chiltern, Toxikon.Who is similar to Linical Accelovance?
Medpace is the most similar to Linical Accelovance. Chiltern and Toxikon are also similar to Linical Accelovance.
Are Linical Accelovance and Medpace competitors?
Yes, Medpace is one of Linical Accelovance’s top competitors.